Status:
COMPLETED
Study Evaluating Epidemiology of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in Australia
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Ankylosing Spondylitis
Psoriatic Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
The study is a cross sectional, epidemiology study of disease severity for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis in four geographic regions in Australia (Illawarra, Suth...
Eligibility Criteria
Inclusion
- Inclusion criteria include:
- Adult patients with a diagnosis of rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis who have visited a primary care centre within one of the specified catchment areas for their condition within the last 24 months.
Exclusion
Key Trial Info
Start Date :
November 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
559 Patients enrolled
Trial Details
Trial ID
NCT00751387
Start Date
November 1 2008
End Date
September 1 2009
Last Update
November 30 2010
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Georgetown, Australia, 2298
2
Miranda, Australia, 2228
3
Newcastle, Australia, 2300
4
Wollongong, Australia, 2500